Copyright
©The Author(s) 2015.
World J Pharmacol. Mar 9, 2015; 4(1): 47-57
Published online Mar 9, 2015. doi: 10.5497/wjp.v4.i1.47
Published online Mar 9, 2015. doi: 10.5497/wjp.v4.i1.47
Type | Relevant ME | Metastases | Costs | Ease | Ref. |
Subcutaneous | No | No | Low | Easy | [51] |
Orthotopic BrCa | Yes | Yes | Low | Easy | [45] |
Orthotopic PCa | Yes | Yes | Medium | Difficult | [55] |
Intratibial | Yes | Yes | Medium | Difficult | [56] |
Intravenous/cardiac | Yes | Yes | Medium | Medium | [60] |
Humanized | Yes | Yes | High | Difficult | [67] |
PDX | Yes | No | High | Difficult | [94] |
- Citation: Valta M, Fagerlund K, Suominen M, Halleen J, Tuomela J. Importance of microenvironment in preclinical models of breast and prostate cancer. World J Pharmacol 2015; 4(1): 47-57
- URL: https://www.wjgnet.com/2220-3192/full/v4/i1/47.htm
- DOI: https://dx.doi.org/10.5497/wjp.v4.i1.47